- xG Technology Inc XGTI shares surged 83.9 percent to $4.23 after the company announced plans to acquire Vislink Communication Systems.
- Globalstar, Inc. GSAT shares rose 41 percent to $1.48 on a Bloomberg article over the weekend saying that the revised Wi-Fi proposal was put on circulation by the FCC.
- Loxo Oncology Inc LOXO shares gained 28.7 percent to $34.63 as the company announced plans for accelerated path to the FDA approval for larotrectinib. The company expects to submit NDA by late 2017 or early 2018.
- Tonix Pharmaceuticals Holding Corp. TNXP shares climbed 23.7 percent to $0.569 after the company disclosed that its PTSD Phase 3-ready drug candidate TNX-102 SL has been given Breakthrough Therapy designation by the FDA.
- Concordia International Corp CXRX gained 15.8 percent to $2.49 after the company issued a business update. The company disclosed that it has paid the 1st installment of its earn-out of £72 million to Cinven related to its acquisition of Amdipharm Mercury. Concordia also terminated its Phase 3 trial for Photodynamic Therapy with Photofrin and eliminated its contract sales team.
- Straight Path Communications Inc STRP shares climbed 14.2 percent to $33.25. Straight Path Communications shares have climbed 42.68 percent over the past 52 weeks, while the S&P 500 index has gained 11.72 percent in the same period.
- Ocular Therapeutix Inc OCUL surged 12.5 percent to $8.94. Ocular Therapeutix shares have dropped 22.44 percent over the past 52 weeks, while the S&P 500 index has gained 11.72 percent in the same period.
- Allied World Assurance Co Holdings, AG. AWH rose 12 percent to $51.26 after Fairfax Financial Holdings Ltd FRFHF agreed to buy the company for $4.9 billion in cash and stock.
- Recro Pharma Inc REPH climbed 11 percent to $7.59. Piper Jaffray initiated coverage on Recro Pharma with an Overweight rating. On Friday, Deerfield Mgmt, L.P. reported a 10.9 percent passive stake in Recro Pharma.
- Brainstorm Cell Therapeutics Inc BCLI gained 7.1 percent to $2.86 after the company disclosed that it has completed a successful end-of-Phase 2 meeting with the FDA.
- DryShips Inc. DRYS shares gained 5.9 percent to $5.20 after dropping 9.07 percent on Friday.
- Lam Research Corporation LRCX rose 3.8 percent to $108.36. Goldman Sachs upgraded Lam Research from Neutral to Buy.
- HubSpot Inc HUBS gained 3.6 percent to $49.10. Raymond James upgraded HubSpot from Outperform to Strong Buy.
- Lennar Corporation LEN shares rose 3 percent to $44.74 after the company posted stronger-than-expected earnings for its fourth quarter on Monday.
- DexCom, Inc. DXCM shares gained around 3 percent to $65.12. Oppenheimer upgraded DexCom from Perform to Outperform.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
